Sino Biopharmaceuticals announced that Sirolimus Tablets (trademark name: Qingweishi) developed by it have received marketing approval from the National Medical Products Administration, which is the first product, since China implemented the early resolution mechanism for drug patent disputes (drug

1. PatentIn 2023, the number of authorized invention patents in China was 921,000, the number of authorized utility model patents was 2.09 million, and the number of authorized industrial design patents was 499,100. Among them, there were 4.015 million valid domestic invention patents (excluding Hon

In the field of solid-state batteries in the green and low-carbon industry, as of May this year, the number of global solid-state battery key technology patent applications was 20,798, of which 7,640 were from China, accounting for 36.7%; in the past 5 years, the average annual growth rate of Chinas

Recently, Huawei Technologies Co., Ltd transferred multiple "STELATO" trademarks it applied and registered for transportation tools to BAIC BJEV.Now, Huawei still has multiple "STELATO" trademark application information, the international classification involves construction repair, website services

The China National Intellectual Property Administration (CNIPA) and the National Institute of Industrial Property of Chile (INAPI) have jointly decided to extend their Patent Prosecution Highway (PPH) pilot program for another five years from January 1, 2024 to December 31, 2028. The established gui